GlassScriptPhysician profile
Shaza Khalid
NPI 1457702466
$1,097.61
in general payments reported to CMS, 2019-2025
19 companies · $70.45 in 2025
The $70.45 reported for 2025 was less than what a typical Infectious Disease provider received nationally (typical 2025 total: $187).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $27.94 · 2021: $32.53 · 2022: $196 · 2023: $413 · 2024: $358 · 2025: $70.45.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $825 · Education: $16.24.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $825.34 |
| Education | $16.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ferring Pharmaceuticals INC. | $261.69 | 2023-2024 | Rebyota |
| Paratek Pharmaceuticals, INC. | $195.62 | 2022-2025 | Nuzyra |
| Organogenesis INC. | $87.65 | 2023-2024 | Puraply |
| Abbvie INC. | $74.24 | 2022-2025 | |
| Molnlycke Health Care US, LLC | $67.88 | 2023-2024 | Exufiber Ag+, Mepilex Border Flex, Mepilex Border Sacrum |
| Integra Lifesciences Corporation | $62.56 | 2023-2024 | Integra, Tcc-Ez, Primatrix |
| Melinta Therapeutics, LLC | $49.34 | 2022 | |
| Smith+Nephew, INC. | $39.37 | 2023 | Collagenase Santyl |
| Insmed, INC. | $38.80 | 2025 | Brinsupri, Arikayce |
| Kerecis Limited | $37.60 | 2023-2024 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Reddress USA, INC. | $32.54 | 2024 | |
| Gilead Sciences, INC. | $32.53 | 2021 | |
| Hydrofera LLC | $21.92 | 2023 | Hydrofera Blue |
| Pfizer INC. | $18.37 | 2023 | |
| Solventum Corporation | $17.55 | 2024 | Activ.A.C. |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kci USA, INC. | $17.30 | 2023 | Activ.A.C. |
| Hikma Pharmaceuticals USA | $15.67 | 2019 | |
| Mimedx Group, INC. | $14.71 | 2024 | |
| Allergan, INC. | $12.27 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shaza Khalid listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.